THEMISMED

THEMIS MEDICARE

Pharmaceuticals Small Cap BSE: 530199 NSE: THEMISMED
₹746.00
-5 (-0.67%)
As on 01 July, 2022 | 08:06

Themis Medicare Share Price

Themis Medicare Performance

Day Range

  • Low 728.1
  • High 750.5

52 Week Range

  • Low 656.65
  • High 1197
  • Open Price 740.8
  • Previous Close 751
  • Volume 335

Themis Medicare Share Returns

  • Over 1 Month -5.42%
  • Over 3 Month -21.32%
  • Over 6 Month -21.14%
  • Over 1 Year 7.31%

Themis Medicare Key Statistics

P/E Ratio 11.2
PEG Ratio 0.1
Market Cap Cr 686.3
Price to Book Ratio 227.1
EPS 66.9
Dividend 50
Relative Strength Index 44.7
Money Flow Index 51.16
MACD Signal -26.91
Average True Range 34.93

Themis Medicare Investment Rating

  • Master Rating:
  • Themis Medicare has an operating revenue of Rs. 394.61 Cr. on a trailing 12-month basis. An annual revenue growth of 71% is outstanding, Pre-tax margin of 21% is great, ROE of 25% is exceptional. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 49 which is a POOR score indicating inconsistency in earnings, a RS Rating of 26 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 90 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Themis Medicare Financials
  • Indicator
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev
    Qtr Cr
  • 79.80
  • 94.92
  • 107.39
  • 112.50
  • 61.77
  • Operating Expenses
    Qtr Cr
  • 65.38
  • 77.63
  • 83.93
  • 72.03
  • 49.17
  • Operating Profit
    Qtr Cr
  • 14.42
  • 17.29
  • 23.46
  • 40.48
  • 12.61
  • Depreciation
    Qtr Cr
  • 2.39
  • 2.37
  • 2.38
  • 2.35
  • 2.38
  • Interest
    Qtr Cr
  • 1.93
  • 2.13
  • 2.05
  • 2.67
  • 3.09
  • Tax
    Qtr Cr
  • 4.39
  • 4.79
  • 4.13
  • 9.07
  • 1.20
  • Net Profit
    Qtr Cr
  • 7.55
  • 12.15
  • 15.12
  • 26.73
  • 6.82

Themis Medicare Technicals

EMA & SMA

Current Price
747.25
-3.75 (-0.5%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • 756.84
  • 50 Day
  • 808.27
  • 100 Day
  • 862.3
  • 200 Day
  • 931.07
  • 20 Day
  • 754.49
  • 50 Day
  • 813.36
  • 100 Day
  • 903.65
  • 200 Day
  • 931.58

Themis Medicare Resistance and Support

PIVOT
₹745.32
Resistance
  • First Resistance
  • 756.69
  • Second Resistance
  • 762.37
  • Third Resistance
  • 773.74
Support
  • First Resistance
  • 739.64
  • Second Resistance
  • 728.27
  • Third Resistance
  • 722.59
  • RSI
  • 44.7
  • MFI
  • 51.16
  • MACD Single Line
  • -26.91
  • MACD
  • -22.47

Themis Medicare Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 382
  • 21,701
  • 56.81
  • Week
  • 1,004
  • 70,537
  • 70.27
  • 1 Month
  • 1,820
  • 146,998
  • 80.76
  • 6 Month
  • 4,833
  • 345,191
  • 71.43

Themis Medicare Result Highlights

Themis Medicare Synopsis

NSE-Medical-Generic Drugs

Themis Medicare Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 230.67 Cr. and Equity Capital is Rs. 9.19 Cr. for the Year ended 31/03/2021. Themis Medicare Ltd. is a Public Limited Listed company incorporated on 31/05/1969 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1969PLC001590 and registration number is 001590.
  • Market Cap
  • 687.47
  • Sales
  • 394.61
  • Shares in Float
  • 0.30
  • No of funds
  • 1
  • Yield
  • 0.67
  • Book Value
  • 2.82
  • U/D Vol ratio
  • 0.7
  • LTDebt / Equity
  • 10
  • Alpha
  • 0.04
  • Beta
  • 0.93

Themis Medicare

  • Owner Name
  • Jun -21
  • Promoters
  • 67.22%
  • Foreign Portfolio Investors
  • %
  • Financial Institutions/ Banks
  • 0.01%
  • Individual Investors
  • 22.99%
  • Others
  • 9.78%

Themis Medicare Management

  • Name
  • Designation
  • Mr. Hoshang Sinor
  • Chairman & Ind.Director
  • Dr. Dinesh S Patel
  • Executive Vice Chairman
  • Dr. Sachin D Patel
  • Managing Director & CEO
  • Mrs. Jayshree D Patel
  • Whole Time Director
  • Dr. Gabor Gulacsi
  • Non Executive Director
  • Mr. Lajos Kovacs
  • Non Executive Director
  • Mr. Rajneesh Anand
  • Non Executive Director
  • Mr. Vijay G Agarwal
  • Independent Director
  • Mr. Hariharan Subramaniam
  • Independent Director
  • Mr. Humayun Dhanrajgir
  • Independent Director
  • Ms. Manjul Sandhu
  • Independent Director
  • Mrs. Reena S Patel
  • Alternate Director

Themis Medicare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Themis Medicare Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-05-21
  • Audited Results & Final Dividend
  • 2022-02-11
  • Quarterly Results
  • 2021-11-12
  • Quarterly Results
  • 2021-08-13
  • Quarterly Results
  • 2021-05-27
  • Audited Results & Final Dividend

Themis Medicare MF Shareholding

  • Name
  • Amount(cr)
  • Quant Small Cap Fund Growth
  • 1753.58

Themis Medicare Similar Stocks

  • 52 week
  • 1,917.00
  • Market price
  • 1,500.00 (0.14%)
  • Volume
  • 914
  • 52 week
  • 699.95
  • Market price
  • 554.15 (-1.32%)
  • Volume
  • 6726
  • 52 week
  • 345.00
  • Market price
  • 245.00 (3.01%)
  • Volume
  • 2249
Company Name
Albert David Ltd
  • 52 week
  • 738.40
  • Market price
  • 519.10 (-1.78%)
  • Volume
  • 99

Themis Medicare News

THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window

We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 2nd April, 2019 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from Friday 1st July, 2022 and will re-open after completion of 48 hours from the declaration of financial results for the quarter ended 30th June, 2022 by the Board of Directors of the Company.

THEMIS MEDICARE LTD. - 530199 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Themis Medicare Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

THEMIS MEDICARE LTD. - 530199 - Declaration Of Voting Results Of Postal Ballot (E-Voting)

Pursuant to Regulation 44(3) of the SEBI (LODR) Regulations, 2015, we are enclosing herewith the Report submitted by the Scrutinizer i.e. Mr. Shirish Shetye (FCS 1926), Designated Partners of M/s. SAV & Associates LLP, Practicing Company Secretaries, Mumbai along with the voting results declared on (Friday) June 17, 2022, with respect to the Postal Ballot (e-voting) conducted by the Company for seeking approval of the Members by way of Special/Ordinary Resolution for the following Special Business contained in the Postal Ballot Notice dated May 10, 2022: 1. RE-APPOINTMENT OF DR. DINESH S. PATEL AS THE WHOLE TIME DIRECTOR OF THE COMPANY. 2. RE-APPOINTMENT OF DR. SACHIN D. PATEL AS THE MANAGING DIRECTOR & CHIEF EXECUTIVE OFFICER OF THE COMPANY. A duly certified copy of the Report of the Scrutinizer in this regard is also enclosed herewith. Kindly acknowledge the receipt and take the same on your record.

THEMIS MEDICARE LTD. - 530199 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements), 2015

Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of Related Party Transactions on a consolidated basis for the half year ended 31st March 2022. Kindly take the same on your records.

THEMIS MEDICARE LTD. - 530199 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) read with SEBI Circular CIR/CFD/ CMD1/27/2019 dated February 8, 2019, please find enclosed the Annual Secretarial Compliance Report of the Company issued by SAV & Associates LLP, Company Secretaries for the financial year 2021 -22. This is for the information of the exchange and the members.

Themis Medicare FAQs

What is Share Price of Themis Medicare ?

Themis Medicare share price is ₹746 As on 01 July, 2022 | 07:52

What is the Market Cap of Themis Medicare ?

The Market Cap of Themis Medicare is ₹686.3 As on 01 July, 2022 | 07:52

What is the P/E ratio of Themis Medicare ?

The P/E ratio of Themis Medicare is 9.4 As on 01 July, 2022 | 07:52

What is the PB ratio of Themis Medicare ?

The PB ratio of Themis Medicare is 2.4 As on 01 July, 2022 | 07:52